Striving for Clinical Remission in Rheumatoid Arthritis

Save

How do you measure remission in your patients with RA? There are multiple composite measures that can be reliably utilized in clinical practice to assess disease activity and remission. This article highlights these measures and how treatment with upadacitinib, with or without MTX, was assessed across multiple measures of remission in the SELECT program.

Safety Profile of RINVOQ™ (upadacitinib): Analysis of Up to ~3.5 Years of Exposure in Patients With Rheumatoid Arthritis

Save

Presented here is an update on the longer-term safety profile of upadacitinib, drawing on the integrated analysis of up to ~3.5 years of exposure data from five Phase 3 studies. Dr. Winthrop and Dr. Cush provide additional information from relevant EULAR 2020 posters.

COVID-19 Patient PSA Video Series

Save

Dr. Jack Cush provides a series of "Patient Safety Advisories" on how patients can cope with the COVID-19 pandemic and rheumatology-related illnesses.

Biosimilars in Rheumatology

Save

A first-of-its kind educational video series focusing on the “hot topics” in biosimilars from the perspective of leading Rheumatology experts. This educational series is presented by Sandoz, Inc.

Therapeutic Update: Rheumatoid Arthritis: Redefined

Save

The RA Redefined video matrix aims to educate on the evolving understanding behind the pathophysiology of rheumatoid arthritis (RA), the role of autoantibodies and cytokines in the disease, and how T cells and B cells perpetuate RA.

Best of EULAR 2018

Save

A video matrix of the best moments and findings from our coverage of EULAR 2018 in Amsterdam